Clinical Study
Biologic Agents—A Panacea for Inflammatory Arthritis or Not?
Table 1
Baseline demographic and clinical characteristics.
| | Diagnosis | RA () | PsA () | AS () |
| | Mean age (years sd) | 62.35 () | 51.7 () | 48.8 () | | Sex (m : f) | | | | | Mean duration of illness (years ± sd) | 14.7 () | 12.6 () | 12.6 () | | Tender and swollen joint count or BASDAI (AS patients) | 25.9 () | 25.7 () | 7.8 () | | Mean CRP (mg/L) | 43.5 () | 58.8 () | 47.1 () | | Mean ESR (mm/hr) | 46.9 () | 36.8 () | 38.8 () | | % use of Corticosteroids | 50.5 | 12 | 5 | | % use of Methotrexate | 50.5 | 38.5 | 20 | | % chronic pain, Fibromyalgia | 16.7% | 15.8% | 7.1% |
|
|
sd: standard deviation, BASDAI: Bath Ankylosing Spondylitis Disease Activity Index, RA: Rheumatoid Arthritis, PsA: Psoriatic Arthritis, AS: Ankylosing Spondylitis, CRP: C Reactive Protein, ESR: Erythrocyte Sedimentation Rate.
|
